CHU Rennes, Univ Rennes, F-35000 Rennes, France.
Department of Public Health, University Hospital of Pontchaillou, Rennes, France.
Clin Res Hepatol Gastroenterol. 2022 Nov;46(9):101974. doi: 10.1016/j.clinre.2022.101974. Epub 2022 Jun 9.
The identification of early prognostic factors during Crohn's disease (CD) remains needed for physician decision-making to minimize structural bowel damage, which this study aimed to assess in a population-based setting.
All incident cases of CD were prospectively registered from 1994 to 1997 in Brittany, a limited area of France. All charts of patients were reviewed from the diagnosis to the last clinic visit in 2015. Disabling CD course was defined according to the Saint-Antoine criteria.
Among the 331 incident cases of CD, 272 (82%) were followed-up for a median time of 12.8 years. The cumulative probability of developing stricturing or fistulizing CD was 66% at 15 years, and 107 (39%) patients underwent surgery. The cumulative probabilities of immunosuppressant and TNF antagonist use at 15 years were 37% and 22%, respectively. The cumulative risks for disabling disease and bowel damage were 74% and 71% at 15 years, respectively. Systemic symptoms and perianal lesions at diagnosis were independently associated with a disabling disease course. Perianal disease and short disease extension were associated with the onset of bowel damage. Deep ulcers was not predictive of any outcome.
A disabling disease course and bowel damage occurred early in the course of CD, which suggests the need for early diagnosis and early treatment, particularly for patients with systematic symptoms and perianal disease.
在克罗恩病(CD)中,识别早期预后因素对于医生的决策仍然是必要的,以最大限度地减少结构肠损伤,本研究旨在人群中评估这一因素。
1994 年至 1997 年,法国布列塔尼的一个有限地区前瞻性登记了所有的 CD 新发病例。从诊断到 2015 年的最后一次临床就诊,对所有患者的病历进行了回顾。根据 Saint-Antoine 标准,定义了致残性 CD 病程。
在 331 例新发病例中,272 例(82%)中位随访时间为 12.8 年。15 年内发生狭窄或瘘管性 CD 的累积概率为 66%,107 例(39%)患者接受了手术。15 年内免疫抑制剂和 TNF 拮抗剂使用的累积概率分别为 37%和 22%。15 年内致残性疾病和肠损伤的累积风险分别为 74%和 71%。诊断时的全身症状和肛周病变与致残性疾病病程独立相关。肛周疾病和疾病扩展短与肠损伤的发生有关。深溃疡不能预测任何结局。
CD 病程中很早就出现了致残性疾病和肠损伤,这表明需要早期诊断和早期治疗,特别是对于有系统性症状和肛周疾病的患者。